List of Tables
Table 1. Global Solid Oral Nutraceutical Excipient Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Solid Oral Nutraceutical Excipient Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Solid Oral Nutraceutical Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Solid Oral Nutraceutical Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Solid Oral Nutraceutical Excipient Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Solid Oral Nutraceutical Excipient Sales by Region (2020-2025) & (K Units)
Table 8. Global Solid Oral Nutraceutical Excipient Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Solid Oral Nutraceutical Excipient Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Solid Oral Nutraceutical Excipient Sales Share by Manufacturers (2020-2025)
Table 12. Global Solid Oral Nutraceutical Excipient Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Solid Oral Nutraceutical Excipient Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Solid Oral Nutraceutical Excipient by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Oral Nutraceutical Excipient as of 2024)
Table 16. Global Solid Oral Nutraceutical Excipient Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Solid Oral Nutraceutical Excipient Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Solid Oral Nutraceutical Excipient Manufacturing Base and Headquarters
Table 19. Global Solid Oral Nutraceutical Excipient Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Solid Oral Nutraceutical Excipient Sales by Type (2020-2025) & (K Units)
Table 23. Global Solid Oral Nutraceutical Excipient Sales by Type (2026-2031) & (K Units)
Table 24. Global Solid Oral Nutraceutical Excipient Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Solid Oral Nutraceutical Excipient Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Solid Oral Nutraceutical Excipient ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Solid Oral Nutraceutical Excipient Sales by Application (2020-2025) & (K Units)
Table 29. Global Solid Oral Nutraceutical Excipient Sales by Application (2026-2031) & (K Units)
Table 30. Solid Oral Nutraceutical Excipient High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Solid Oral Nutraceutical Excipient Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Solid Oral Nutraceutical Excipient Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Solid Oral Nutraceutical Excipient ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Solid Oral Nutraceutical Excipient Growth Accelerators and Market Barriers
Table 37. North America Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Solid Oral Nutraceutical Excipient Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Solid Oral Nutraceutical Excipient Growth Accelerators and Market Barriers
Table 40. Europe Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Solid Oral Nutraceutical Excipient Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Solid Oral Nutraceutical Excipient Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Solid Oral Nutraceutical Excipient Growth Accelerators and Market Barriers
Table 45. Southeast Asia Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Solid Oral Nutraceutical Excipient Investment Opportunities and Key Challenges
Table 47. Central and South America Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Solid Oral Nutraceutical Excipient Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Solid Oral Nutraceutical Excipient Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Kerry Group Corporation Information
Table 51. Kerry Group Description and Major Businesses
Table 52. Kerry Group Product Models, Descriptions and Specifications
Table 53. Kerry Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Kerry Group Sales Value Proportion by Product in 2024
Table 55. Kerry Group Sales Value Proportion by Application in 2024
Table 56. Kerry Group Sales Value Proportion by Geographic Area in 2024
Table 57. Kerry Group Solid Oral Nutraceutical Excipient SWOT Analysis
Table 58. Kerry Group Recent Developments
Table 59. Cargill Corporation Information
Table 60. Cargill Description and Major Businesses
Table 61. Cargill Product Models, Descriptions and Specifications
Table 62. Cargill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Cargill Sales Value Proportion by Product in 2024
Table 64. Cargill Sales Value Proportion by Application in 2024
Table 65. Cargill Sales Value Proportion by Geographic Area in 2024
Table 66. Cargill Solid Oral Nutraceutical Excipient SWOT Analysis
Table 67. Cargill Recent Developments
Table 68. BASF Corporation Information
Table 69. BASF Description and Major Businesses
Table 70. BASF Product Models, Descriptions and Specifications
Table 71. BASF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. BASF Sales Value Proportion by Product in 2024
Table 73. BASF Sales Value Proportion by Application in 2024
Table 74. BASF Sales Value Proportion by Geographic Area in 2024
Table 75. BASF Solid Oral Nutraceutical Excipient SWOT Analysis
Table 76. BASF Recent Developments
Table 77. Ingredion Corporation Information
Table 78. Ingredion Description and Major Businesses
Table 79. Ingredion Product Models, Descriptions and Specifications
Table 80. Ingredion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Ingredion Sales Value Proportion by Product in 2024
Table 82. Ingredion Sales Value Proportion by Application in 2024
Table 83. Ingredion Sales Value Proportion by Geographic Area in 2024
Table 84. Ingredion Solid Oral Nutraceutical Excipient SWOT Analysis
Table 85. Ingredion Recent Developments
Table 86. Roquette Freres Corporation Information
Table 87. Roquette Freres Description and Major Businesses
Table 88. Roquette Freres Product Models, Descriptions and Specifications
Table 89. Roquette Freres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Roquette Freres Sales Value Proportion by Product in 2024
Table 91. Roquette Freres Sales Value Proportion by Application in 2024
Table 92. Roquette Freres Sales Value Proportion by Geographic Area in 2024
Table 93. Roquette Freres Solid Oral Nutraceutical Excipient SWOT Analysis
Table 94. Roquette Freres Recent Developments
Table 95. JRS Pharma Corporation Information
Table 96. JRS Pharma Description and Major Businesses
Table 97. JRS Pharma Product Models, Descriptions and Specifications
Table 98. JRS Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. JRS Pharma Recent Developments
Table 100. Evonik Corporation Information
Table 101. Evonik Description and Major Businesses
Table 102. Evonik Product Models, Descriptions and Specifications
Table 103. Evonik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Evonik Recent Developments
Table 105. Ashland Corporation Information
Table 106. Ashland Description and Major Businesses
Table 107. Ashland Product Models, Descriptions and Specifications
Table 108. Ashland Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Ashland Recent Developments
Table 110. Colorcon Corporation Information
Table 111. Colorcon Description and Major Businesses
Table 112. Colorcon Product Models, Descriptions and Specifications
Table 113. Colorcon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Colorcon Recent Developments
Table 115. BENEO Corporation Information
Table 116. BENEO Description and Major Businesses
Table 117. BENEO Product Models, Descriptions and Specifications
Table 118. BENEO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. BENEO Recent Developments
Table 120. Azelis Corporation Information
Table 121. Azelis Description and Major Businesses
Table 122. Azelis Product Models, Descriptions and Specifications
Table 123. Azelis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Azelis Recent Developments
Table 125. SEPPIC Corporation Information
Table 126. SEPPIC Description and Major Businesses
Table 127. SEPPIC Product Models, Descriptions and Specifications
Table 128. SEPPIC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. SEPPIC Recent Developments
Table 130. Biogrund Corporation Information
Table 131. Biogrund Description and Major Businesses
Table 132. Biogrund Product Models, Descriptions and Specifications
Table 133. Biogrund Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Biogrund Recent Developments
Table 135. Sigachi Industries Corporation Information
Table 136. Sigachi Industries Description and Major Businesses
Table 137. Sigachi Industries Product Models, Descriptions and Specifications
Table 138. Sigachi Industries Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Sigachi Industries Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Solid Oral Nutraceutical Excipient Product Picture
Figure 2. Global Solid Oral Nutraceutical Excipient Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Natural Product Picture
Figure 4. Synthetic Product Picture
Figure 5. Global Solid Oral Nutraceutical Excipient Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Protein Supplements
Figure 7. Probiotic Supplements
Figure 8. Vitamin Supplements
Figure 9. Mineral Supplements
Figure 10. Others
Figure 11. Solid Oral Nutraceutical Excipient Report Years Considered
Figure 12. Global Solid Oral Nutraceutical Excipient Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 14. Global Solid Oral Nutraceutical Excipient Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Solid Oral Nutraceutical Excipient Revenue Market Share by Region (2020-2031)
Figure 16. Global Solid Oral Nutraceutical Excipient Sales (2020-2031) & (K Units)
Figure 17. Global Solid Oral Nutraceutical Excipient Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Solid Oral Nutraceutical Excipient Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Solid Oral Nutraceutical Excipient Sales Volume Market Share in 2024
Figure 20. Global Solid Oral Nutraceutical Excipient Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Natural Revenue Market Share by Manufacturer in 2024
Figure 23. Synthetic Revenue Market Share by Manufacturer in 2024
Figure 24. Global Solid Oral Nutraceutical Excipient Sales Market Share by Type (2020-2031)
Figure 25. Global Solid Oral Nutraceutical Excipient Revenue Market Share by Type (2020-2031)
Figure 26. Global Solid Oral Nutraceutical Excipient Sales Market Share by Application (2020-2031)
Figure 27. Global Solid Oral Nutraceutical Excipient Revenue Market Share by Application (2020-2031)
Figure 28. North America Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 29. North America Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 31. North America Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 41. Europe Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 46. France Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 61. India Solid Oral Nutraceutical Excipient Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Solid Oral Nutraceutical Excipient Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Solid Oral Nutraceutical Excipient Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Solid Oral Nutraceutical Excipient Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Solid Oral Nutraceutical Excipient Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Solid Oral Nutraceutical Excipient Revenue (2020-2025) & (US$ Million)
Figure 82. Solid Oral Nutraceutical Excipient Industry Chain Mapping
Figure 83. Regional Solid Oral Nutraceutical Excipient Manufacturing Base Distribution (%)
Figure 84. Global Solid Oral Nutraceutical Excipient Production Market Share by Region (2020-2031)
Figure 85. Solid Oral Nutraceutical Excipient Production Process
Figure 86. Regional Solid Oral Nutraceutical Excipient Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
